Truepill

Truepill is a digital health platform connecting telehealth, diagnostics, and pharmacy to power the future of consumer healthcare.

Truepill empowers its partners to deliver world-class patient experiences through our API-connected healthcare infrastructure.

Truepill was founded in 2016 by Umar Afridi and Sid Viswanathan. The company is headquartered in San Mateo, California.

 

Truepill’s unique B2B model builds direct-to-patient experiences across the entire healthcare ecosystem, working with health plans, pharmaceutical manufacturers and consumer health brands alike. 

 

Truepill's expansive suite of customizable, direct-to-patient solutions includes industry-first API technology, nationwide prescription fulfillment and delivery, a US-based network of licensed telehealth providers, white label packaging, product design and more.

 

Truepill has shipped nearly 10 million prescriptions, processed nearly one million diagnostic tests and facilitated over 50,000 telehealth visits per week (to date). Customers include GoodRx, TherapeuticsMD, K Health, hims & hers, Nurx, Simple Health and more.

 

Truepill is backed by Oak HC/FT, Initialized Capital, TI Platform Management, Optum Ventures, YCombinator, Sound Ventures, and others. The company raised $142M in Series D round on Oct 27, 2021. This brings Truepill's total funding to $256M to date. The latest round gives the company a valuation of $1.6B post-money.

 

 

  • Year founded: 2016
  • Funding Info: $256M over 6 Rounds (Latest Funding Type: Series D)
  • Yearly Revenue: NA
  • Employee Size: 201-500
  • Business Valuation: Valued at $1.6B as of Oct 27, 2021
  • City/Town: San Mateo
  • State: California
  • Country: United States
Related businesses